Time course of response to antidepressants: Predictive value of early improvement and effect of additional psychotherapy

Journal of Affective Disorders

Volumn 114, Issue 1-3, 2009, Pages 243-253

  van Calker, Dietrich ^a   Zobel, Ingo ^a   Dykierek, Petra ^a   Deimel, Christoph Michael ^a   Kech, Sabine ^a   Lieb, Klaus ^a   Berger, Mathias ^a   Schramm, Elisabeth ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Amitriptyline; Interpersonal Psychotherapy; Sertraline; Survival analysis

Indexed keywords

AMITRIPTYLINE; SERTRALINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; HAMILTON SCALE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PSYCHOTHERAPY; RESPONSE TIME; SURVIVAL;

ADOLESCENT; ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SERTRALINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59649113979     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.07.023     Document Type: Article

References (40)

1. Angst J., Delini-Stula A., Stabl M., and Stassen H.H. Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis. Hum. Psychopharmacol. 8 (1993) 311-317
2. DiMascio A., Weissman M.M., Prusoff B.A., Neu C., Zwilling M., and Klerman G.L. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch. Gen. Psychiatry 36 (1979) 1450-1456
3. Fava G.A., Fabbri S., and Sonino N. Residual symptoms in depression: an emerging therapeutic target. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002) 1019-1027
4. Fava G.A., Ruini C., and Sonino N. Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs 17 (2003) 1109-1117
5. First M., Spitzer R., Gibbon M., and Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders: patient edition (1997), Biometrics Research Dept, New York State Psychiatric Institute, New York
6. Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., Thase M.E., McEachran A.B., and Grochocinski V.J. Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry 47 (1990) 1093-1099
7. Hamilton M.A. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-63
8. Hollon S.D., Jarrett R.B., Nierenberg A.A., Thase M.E., Trivedi M., and Rush A.J. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?. J. Clin. Psychiatry 66 (2005) 455-468
9. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
10. Katz M.M., Tekell J.L., Bowden C.L., Brannan S., Houston J.P., Berman N., and Frazer A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 29 (2004) 566-579
11. Keller M.B., McCullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., Markowitz J.C., Nemeroff C.B., Russell J.M., Thase M.E., Trivedi M.H., and Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342 (2000) 1462-1470
12. Klerman G.L., Weissman M., Rounsaville B.J., and Chevron E.S. Interpersonal Psychotherapy of Depression (1984), Basic Books, New York
13. Laska E.M., and Siegel C. Characterizing onset in psychopharmacological clinical trials. Psychopharmacol. Bull. 31 (1995) 29-35
14. Lenze E.J., Dew M.A., Mazumdar S., Begley A.E., Cornes C., Miller M.D., Imber S.D., Frank E., Kupfer D.J., and Reynolds III C.F. Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment. Am. J. Psychiatry 159 (2002) 466-468
15. Li Y., and Feng J. A nonparametric comparison of conditional distributions with nonnegligible cure fractions. Lifetime Data Anal. 11 (2005) 367-387
16. Lydiard R.B., Stahl S.M., Hertzman M., and Harrison W.M. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J. Clin. Psychiatry 58 (1997) 484-491
17. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65 (2003) 193-207
18. McIntyre R.S., and O'Donovan C. The human cost of not achieving full remission in depression. Can. J. Psychiatry 49 (2004) 10S-16S
19. Moller H.J., Gallinat J., Hegerl U., Arato M., Janka Z., Pflug B., and Bauer H. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression. Pharmacopsychiatry 31 (1998) 170-177
20. Montgomery S.A., Bech P., Blier P., Moller H.J., Nierenberg A.A., Pinder R.M., Quitkin F.M., Reimitz P.E., Rosenbaum J.F., Rush A.J., Stassen H.H., and Thase M.E. Selecting methodologies for the evaluation of differences in time to response between antidepressants. J. Clin. Psychiatry 63 (2002) 694-699
21. Nierenberg A.A., Farabaugh A.H., Alpert J.E., Gordon J., Worthington J.J., Rosenbaum J.F., and Fava M. Timing of onset of antidepressant response with fluoxetine treatment. Am. J. Psychiatry 157 (2000) 1423-1428
22. Papakostas G.I., Perlis R.H., Scalia M.J., Petersen T.J., and Fava M. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J. Clin. Psychopharmacol. 26 (2006) 56-60
23. Posternak M.A., and Zimmerman M. Drs. Posternak and Zimmerman reply. J. Clin. Psychiatry 66 (2005) 1193
24. Posternak M.A., and Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J. Clin. Psychiatry 66 (2005) 148-158
25. Quitkin F.M., Rabkin J.G., Stewart J.W., McGrath P.J., Harrison W., Ross D.C., Tricamo E., Fleiss J., Markowitz J., and Klein D.F. Heterogeneity of clinical response during placebo treatment. Am. J. Psychiatry 148 (1991) 193-196
26. Quitkin F.M., McGrath P.J., Stewart J.W., Ocepek-Welikson K., Taylor B.P., Nunes E., Deliyannides D., Agosti V., Donovan S.J., Petkova E., and Klein D.F. Chronological milestones to guide drug change. When should clinicians switch antidepressants?. Arch. Gen. Psychiatry 53 (1996) 785-792
27. Quitkin F.M., Petkova E., McGrath P.J., Taylor B., Beasley C., Stewart J., Amsterdam J., Fava M., Rosenbaum J., Reimherr F., Fawcett J., Chen Y., and Klein D. When should a trial of fluoxetine for major depression be declared failed?. Am. J. Psychiatry 160 (2003) 734-740
28. Quitkin F.M., McGrath P.J., Stewart J.W., Klein D.F., and Ross D.C. Accurate meta-analytical assessment of "true antidepressant effects" needed. J. Clin. Psychiatry 66 (2005) 1192-1193
29. R Development Core Team. A Language and Environment for Statistical Computing (2004), R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org ISBN 3-900051-07-0, URL http://www.R-project.org
30. Reimherr F.W., Chouinard G., Cohn C.K., Cole J.O., Itil T.M., LaPierre Y.D., Masco H.L., and Mendels J. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J. Clin. Psychiatry 51 Suppl B (1990) 18-27
31. Reynolds III C.F., Frank E., Perel J.M., Imber S.D., Cornes C., Miller M.D., Mazumdar S., Houck P.R., Dew M.A., Stack J.A., Pollock B.G., and Kupfer D.J. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281 (1999) 39-45
32. Schramm E., van Calker D., Dykierek P., Lieb K., Kech S., Zobel I., Leonhart R., and Berger M. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am. J. Psychiatry 164 (2007) 768-777
33. Schulberg H.C., Block M.R., Madonia M.J., Scott C.P., Rodriguez E., Imber S.D., Perel J., Lave J., Houck P.R., and Coulehan J.L. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch. Gen. Psychiatry 53 (1996) 913-919
34. Stassen H.H., Delini-Stula A., and Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur. Neuropsychopharmacol. 3 (1993) 127-135
35. Stassen H.H., Angst J., and Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry 29 (1996) 87-96
36. Stassen H.H., Angst J., Hell D., Scharfetter C., and Szegedi A. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. J. Clin. Psychiatry 68 8 (2007) 1195-1205
37. Szegedi A., Muller M.J., Anghelescu I., Klawe C., Kohnen R., and Benkert O. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J. Clin. Psychiatry 64 (2003) 413-420
38. Tamura R.N., Faries D.E., and Feng J. Comparing time to onset of response in antidepressant clinical trials using the cure model and the Cramer-von Mises test. Stat. Med. 19 (2000) 2169-2184
39. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., and Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163 (2006) 28-40
40. Watkins J.T., Leber W.R., Imber S.D., Collins J.F., Elkin I., Pilkonis P.A., Sotsky S.M., Shea M.T., and Glass D.R. Temporal course of change of depression. J. Consult. Clin. Psychol. 61 (1993) 858-864